NO CSF BIOMARKER EVIDENCE OF PERSISTING CNS INFECTION AFTER SARS-CoV-2 INFECTION.

MLA

Eden, Arvid, et al. “NO CSF BIOMARKER EVIDENCE OF PERSISTING CNS INFECTION AFTER SARS-CoV-2 INFECTION.” Topics in Antiviral Medicine, vol. 31, no. 2, Apr. 2023, pp. 77–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303442&authtype=sso&custid=ns315887.

APA

Eden, A., Grahn, A., Kanberg, N., Stentoft, E., Nilsson, S., Yilmaz, A., Bremell, D., Studahl, M., Romero, D., Mingyue Wang, Stengelin, M., Sigal, G., Schöll, M., Zetterberg, H., & Gisslen, M. (2023). NO CSF BIOMARKER EVIDENCE OF PERSISTING CNS INFECTION AFTER SARS-CoV-2 INFECTION. Topics in Antiviral Medicine, 31(2), 77–78.

Chicago

Eden, Arvid, Anna Grahn, Nelly Kanberg, Erika Stentoft, Staffan Nilsson, Aylin Yilmaz, Daniel Bremell, et al. 2023. “NO CSF BIOMARKER EVIDENCE OF PERSISTING CNS INFECTION AFTER SARS-CoV-2 INFECTION.” Topics in Antiviral Medicine 31 (2): 77–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303442&authtype=sso&custid=ns315887.